US2018071345A1PendingUtilityA1
Probiotics and methods of obtaining same
Est. expiryMay 31, 2031(~4.8 yrs left)· nominal 20-yr term from priority
A61P 1/14C12Q 1/689A23L 33/00A61K 35/744A23L 33/135A61K 35/745A61K 35/74
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A foodstuff comprising:
a pharmaceutically acceptable carrier selected from the group consisting of a liquid-based carrier, a gel-based carrier, an oleaginous carrier, and an emulsion; and a microbial strain Bifidobacterium adolescentis BD1.
3 . The foodstuff of claim 2 , wherein the foodstuff is selected from the group consisting of milk, yogurt, juices, water, cereals, chewing gum, crackers, candies, cookies, vitamin supplements, meats, blended fruits, and blended vegetables.
4 . The foodstuff of claim 2 , wherein the foodstuff is a dry animal feed or a liquid animal feed.
5 . The foodstuff of claim 2 , wherein the foodstuff further comprises a prebiotic.
6 . The foodstuff of claim 2 , wherein the prebiotic is selected from the group consisting of galactooligosaccharide (GOS), fructooligosaccharide (FOS), and inulin.
7 . The foodstuff of claim 6 , wherein the prebiotic is GOS.
8 . A composition comprising:
a pharmaceutically acceptable carrier selected from the group consisting of a liquid-based carrier, a gel-based carrier, an oleaginous carrier, and an emulsion; and a microbial strain Bifidobacterium adolescentis BD1.
9 . The composition of claim 8 , wherein the composition is formulated as a powder, a granule, a tablet, a capsule, a liquid suspension, a paste, or a syrup.
10 . The composition of claim 2 , wherein the prebiotic is selected from the group consisting of galactooligosaccharide (GOS), fructooligosaccharide (FOS), and inulin.
11 . The composition of claim 10 , wherein the prebiotic is GOS.
12 . A method for establishing or maintaining a healthy gastrointestinal flora in an animal, said method comprising:
administering to said animal an effective amount of a composition comprising microbial strain Bifidobacterium adolescentis BD1.
13 . The method of claim 12 , wherein the animal is a human.
14 . The method of claim 12 , wherein the effective amount is from about 10 2 CFU/day to about 10 12 CFU/day.
15 . The method of claim 12 , wherein the composition is formulated as a powder, a granule, a tablet, a capsule, a liquid suspension, a paste, or a syrup.
16 . The method of claim 12 , wherein further administering to said animal a prebiotic.
17 . The method of claim 12 , wherein the prebiotic is selected from the group consisting of galactooligosaccharide (GOS), fructooligosaccharide (FOS), and inulin.
18 . The method of claim 17 , wherein the prebiotic is GOS.
19 . A method for reducing the effects of a gastrointestinal disease in an animal, said method comprising:
administering to said animal an effective amount of a composition comprising microbial strain Bifidobacterium adolescentis BD1.
20 . The method of claim 19 , wherein the GI disease is selected from the group consisting of diarrhea, constipation, loose stool, abdominal inflation, ulcerous colitis, Crohn's disease, irritable bowel syndrome, hypersensitive intestinal syndromes, food toxicity, food allergy, pseudomembranous colitis, hemorrhagic colitis, gastritis, gastroduodenal ulcer, dental caries, and periodontitis.
21 . The method of claim 19 , wherein the animal is a human.
22 . The method of claim 19 , wherein the effective amount is from about 10 2 CFU/day to about 10 12 CFU/day.
23 . The method of claim 19 , wherein the composition is formulated as a powder, a granule, a tablet, a capsule, a liquid suspension, a paste, or a syrup.
24 . The method of claim 19 , wherein further administering to said animal a prebiotic.
25 . The method of claim 19 , wherein the prebiotic is selected from the group consisting of galactooligosaccharide (GOS), fructooligosaccharide (FOS), and inulin.
26 . The method of claim 25 , wherein the prebiotic is GOS.Join the waitlist — get patent alerts
Track US2018071345A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.